Infusion Therapy Market to Eclipse US$ 78.9 Million by 2031, Steered by a Strong CAGR of 6.7%| Transparency Market Research Inc.


The global market is anticipated to see growth from 2021 to 2031 as chronic diseases including cancer, neurological disorders, and gastrointestinal disorders become more prevalent

Wilmington, Delaware, United States, Aug. 25, 2023 (GLOBE NEWSWIRE) — In 2021, the worldwide infusion therapy market was valued at approximately US$ 41.7 billion. This valuation is projected to experience a consistent growth trajectory, with an expected CAGR of 6.7% from 2022 through 2031. By the year 2031, the infusion therapy market is poised to achieve an impressive market worth of US$ 78.9 billion.

The growth of the market is being driven by an increase in hospital-acquired infections (HAIs), which are brought on by contact with contaminated equipment, bedding, and air droplets across facilities. There is a growing need for home infusion treatment to provide the best care and lessen the risk of infection. Another element driving the market is the creation of inexpensive, user-friendly home infusion kits.


Large volume pumps as well as small volume pumps are the two primary kinds of infusion pumps. While tiny pumps are used to distribute hormones and drugs, large volume pumps are utilized for delivering nutrition. In the context of chemotherapy infusion, a pump that regulates the pace and volume of infusion introduces the drugs (from a list of around 100 agents) used for treating cancer.

Chemotherapy drugs are administered via a vein in the patient’s hand or arm. They can also be injected under the skin or infused through a particular port. These drugs keep circulating in the body and combat the illness. The use of sophisticated infusion pumps that may reduce mistakes, like the IP-200 infusion system, is anticipated to drive market expansion.

For more insights into the Market, Request a Sample of this Report –

Connect with our team of research specialists and unlock the optimal solution for driving your business growth

Market Snapshot:

 Report Coverage  Details
 Market Revenue  US$ 41.7 Bn
 Estimated Value  More than US$ 78.9 Bn
 Growth Rate – CAGR  6.7%  
 Forecast Period  2022-2031
 No. of Pages  233 Pages
 Market Segmentation  Product, Indication, Therapy, End-user
 Regions Covered  North America,Europe,Asia Pacific,Latin America,Middle East & Africa
 Companies Covered  B. Braun Melsungen AG,Medtronic plc,Becton, Dickinson and Company,ICU medical (Smiths Medical),Baxter International, Inc.,Polymedicure,BIO-MED,Terumo Medical Corporation,MEDIPRIM GmbH,Fresenius Kabi,Cardinal Health

Key Findings of the Market Report

  • The accessories sector led the global industry in 2021 in terms of products.
  • According to indication, the global market for infusion treatment in 2021 was led by the cancer sector.
  • The antibiotic/antiviral sector led the worldwide market in 2021 in terms of treatment.
  • In 2021, the hospitals end-user sector dominated the world market.
  • Based on region, the market for infusion treatment in North America was thought to be one of the most profitable.

Market Trends for Infusion Therapy

  • In 2021, the hospitals end-user sector dominated the global market. The same trend is likely to exist during the forecast period as well. There has been an increase in instances due to the discovery of new coronavirus strains in various regions of the world. The quantity of hospital admissions has grown as a result.
  • For critical care, many patients—especially the elderly as well as those with serious lung infections—are put on ventilators. Such individuals need continuous intravenous nourishment to maintain appropriate nutrition.

For In-depth Competitive Analysis, Buy Now:

Global Infusion Therapy Regional Market Outlook

Various reasons are propelling the growth of the infusion therapy market in different regions. These are:

  • In 2021, North America held the majority of the global market share, mostly due to a surge in pharmaceuticals and medicines used in infusion treatment to treat chronic and rare disorders.
  • The growth in the number of elderly people, a high incidence of chronic diseases like heart disease, cancer, and diabetes, and the rapid rate of technology development in the healthcare industry all contribute to the region’s worldwide domination.
  • In recent years, there has been a surge in investment in the North American healthcare business. Market expansion in the area has been fueled by an improvement in quality of life brought on by economic development.
  • The market in Asia Pacific is anticipated to expand rapidly over the projected period due to the quick adoption of novel innovations in the field of infusion treatment and the growth in the frequency of chronic illnesses.

Global Infusion Therapy Market: Key Players

  • B. Braun Melsungen AG
  • Medtronic plc
  • Becton, Dickinson and Company
  • ICU medical (Smiths Medical)
  • Baxter International, Inc.
  • Polymedicure
  • Terumo Medical Corporation
  • Fresenius Kabi
  • Cardinal Health

Some developments by the key players in the global market for Infusion Therapy are:

  • B. Braun, one of the top providers of infusion treatment and pain management solutions and a leader in medical technology, gained FDA permission for its Daytona Beach pharmaceutical manufacturing facility in 2022.
  • The business has pledged to invest more than $1 billion in the United States, including the new Daytona Beach plant, to reduce IV fluid shortages by boosting supply and production capability. The company currently has strategically located production facilities on both coasts owing to its current IV solutions facility in Irvine, California.

Request for Customization and Redefine Expectations:

Global Infusion Therapy Market Segmentation


  • Infusion Pumps
    • Ambulatory Infusion Pumps
    • Stationary Infusion Pumps
    • Syringe Infusion Pumps
    • Disposable Pumps
    • Large Volume Pumps
    • Elastomeric Pumps
  • Infusion Set
  • Accessories


  • Cancer
  • Gastrointestinal Diseases/Disorders
  • Congestive Heart Failure
  • Rheumatoid Arthritis
  • Hemophilia
  • Immune Deficiencies
  • Others


  • Antibiotic/Antiviral
  • Anti-coagulation
  • Anti-emetics
  • Blood Component Stimulating Factor
  • Chemotherapy
  • Nutrition
  • Hydration
  • Pain Management


  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Homecare Settings


  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Read More Related Reports:

Navigating Life Science Reagents Industry Demand: Unveiling Market Size, Trends, Analysis, Scope, and Growth Factors

Rehabilitation Robots Market Size 2023-2031 | Divulging Industry Share, Growth Trajectory

Tablet Coatings Industry Sales: 2023-2031 Overview | Scrutinizing Growth Analysis, Future Outlook

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.


Nikhil Sawlani
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.